https://orcid.org/0000-0001-6433-5692
References
- Schwarz DA, Katayama CD, Hedrick SM. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity 1998;9(5):657–668.
- Geserick P, Kaiser F, Klemm U, Kaufmann SHE, Zerrahn J. Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif. Int Immunol 2004;16(10):1535–1548. doi:10.1093/intimm/dxh155
- Neumann B, Zhao L, Murphy K, Gonda TJ. Subcellular localization of the Schlafen protein family. Biochem Biophys Res Commun 2008;370(1):62–66. doi:10.1016/j.bbrc.2008.03.032
- Mavrommatis E, Arslan AD, Sassano A, Hua Y, Kroczynska B, Platanias LC. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma. J Biol Chem 2013;288(46):33006–33015. doi:10.1074/jbc.M113.460741
- Hanson PI, Whiteheart SW. AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol 2005;6:519. doi:10.1038/nrm1684
- Lupas AN, Martin J. AAA proteins. Curr Opin Struct Biol 2002;12(6):746–753.
- Liu F, Zhou P, Wang Q, Zhang M, Li D. The Schlafen family: complex roles in different cell types and virus replication. Cell Biol Int 2018;42(1):2–8. doi:10.1002/cbin.10778
- Yang J-Y, Deng X-Y, Li Y-S, Ma X-C, Feng J-X, Yu B, Chen Y, Luo Y-L, Wang X, Chen M-L, et al. Structure of Schlafen13 reveals a new class of tRNA/rRNA- targeting RNase engaged in translational control. Nat Commun 2018;9(1):1165. doi:10.1038/s41467-018-03544-x
- Bustos O, Naik S, Ayers G, Casola C, Perez-Lamigueiro MA, Chippindale PT, Pritham EJ, de la Casa-Esperón E. Evolution of the Schlafen genes, a gene family associated with embryonic lethality, meiotic drive, immune processes and orthopoxvirus virulence. Gene 2009;447(1):1–11. doi:10.1016/j.gene.2009.07.006
- Fletcher SJ, Johnson B, Lowe GC, Bem D, Drake S, Lordkipanidzé M, Guiú IS, Dawood B, Rivera J, Simpson MA, et al. SLFN14 mutations underlie thrombocytopenia with excessive bleeding and platelet secretion defects. J Clin Invest 2015;125(9):3600–3605. doi:10.1172/JCI80347
- Marconi C, Di Buduo CA, Barozzi S, Palombo F, Pardini S, Zaninetti C, Pippucci T, Noris P, Balduini A, Seri M, et al. SLFN14-related thrombocytopenia: identification within a large series of patients with inherited thrombocytopenia. Thromb Haemost 2016;115(5):1076–1079. doi:10.1160/TH15-11-0884
- Saes JL, Simons A, de Munnik SA, Nijziel MR, Blijlevens NMA, Jongmans MC, van der Reijden BA, Smit Y, Brons PP, van Heerde WL, et al. Whole exome sequencing in the diagnostic workup of patients with a bleeding diathesis. Haemophilia 2019;25(1):127–135. doi:10.1111/hae.13638
- Pisareva VP, Muslimov IA, Tcherepanov A, Pisarev AV. Characterization of novel ribosome-associated endoribonuclease SLFN14 from rabbit reticulocytes. Biochemistry 2015;54(21):3286–3301. doi:10.1021/acs.biochem.5b00302
- Fletcher SJ, Pisareva VP, Khan AO, Tcherepanov A, Morgan NV, Pisarev AV. Role of the novel endoribonuclease SLFN14 and its disease-causing mutations in ribosomal degradation. Rna 2018;24(7):939–949. doi:10.1261/rna.066415.118
- Ricciardi S, Miluzio A, Brina D, Clarke K, Bonomo M, Aiolfi R, Guidotti LG, Falciani F, Biffo S. Eukaryotic translation initiation factor 6 is a novel regulator of reactive oxygen species-dependent megakaryocyte maturation. J Thromb Haemost 2015;13(11):2108–2118. doi:10.1111/jth.13150
- Narla A, Ebert BL. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010;115(16):3196–3205. doi:10.1182/blood-2009-10-178129